(Q30458271)

21 June 2017

Neurologic indications for therapeutic plasma exchange: 2013 update (English)

1 reference

21 June 2017

3

Ted Burns

1 reference

21 June 2017

1

Kelly Gwathmey

1 reference

21 June 2017

Rasheed A Balogun

2

1 reference

21 June 2017

31 May 2014

1 reference

Journal of Clinical Apheresis

21 June 2017

1 reference

21 June 2017

29

1 reference

21 June 2017

4

1 reference

21 June 2017

211-219

1 reference

Therapeutic apheresis in neurological disorders: a survey of the evidence in support of current category I and II indications for therapeutic plasma exchange

21 June 2017

1 reference

The new approach to assignment of ASFA categories--introduction to the fourth special issue: clinical applications of therapeutic apheresis.

21 January 2018

1 reference

Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis

21 January 2018

1 reference

Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.

21 January 2018

1 reference

Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases

21 January 2018

1 reference

Plasma exchange in neuroimmunological disorders: Part 1: Rationale and treatment of inflammatory central nervous system disorders

21 January 2018

1 reference

Plasma exchange in neuroimmunological disorders: part 2. Treatment of neuromuscular disorders

21 January 2018

1 reference

Use of intravenous immunoglobulin and plasma exchange in neurological disease

21 January 2018

1 reference

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

21 January 2018

1 reference

Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

Variants and mimics of Guillain Barré Syndrome

21 January 2018

1 reference

The Guillain-Barré syndrome

21 January 2018

1 reference

Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey.

21 January 2018

1 reference

The epidemiology of Guillain-Barré syndrome

21 January 2018

1 reference

The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study

21 January 2018

1 reference

Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group

21 January 2018

1 reference

The immunobiology of Guillain-Barré syndromes

21 January 2018

1 reference

Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility

21 January 2018

1 reference

Assessment of current diagnostic criteria for Guillain-Barré syndrome

21 January 2018

1 reference

Supportive care for patients with Guillain-Barré syndrome

21 January 2018

1 reference

Ventilatory failure in the Guillain-Barré syndrome

21 January 2018

1 reference

Autonomic involvement in Guillain-Barré syndrome: a review

21 January 2018

1 reference

Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features

21 January 2018

1 reference

Immunotherapy of idiopathic inflammatory neuropathies

21 January 2018

1 reference

Practice parameter: Immunotherapy for Guillain-Barre syndrome: Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

Intravenous immunoglobulin as therapy for pediatric Guillain-Barré syndrome

21 January 2018

1 reference

Guillain-Barré syndrome in childhood: natural course and efficacy of plasmapheresis

21 January 2018

1 reference

Childhood Guillain-Barré syndrome: clinical presentation, diagnosis, and therapy

21 January 2018

1 reference

The role of plasmapheresis in childhood Guillain-Barré syndrome

21 January 2018

1 reference

Guillain-Barré syndrome: an update

21 January 2018

1 reference

21 January 2018

Guillain-Barré syndrome

1 reference

Immunomodulatory therapies in neurologic critical care

21 January 2018

1 reference

Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study

21 January 2018

1 reference

A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

Autoimmune disorders of neuromuscular transmission

21 January 2018

1 reference

Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia

21 January 2018

1 reference

Lifetime course of myasthenia gravis

21 January 2018

1 reference

Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value

21 January 2018

1 reference

Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays

21 January 2018

1 reference

Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience

21 January 2018

1 reference

IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis

21 January 2018

1 reference

AAEM minimonograph #25: single-fiber electromyography

21 January 2018

1 reference

New directions in plasma exchange.

21 January 2018

1 reference

IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial

21 January 2018

1 reference

Remission of myasthenia gravis following plasma-exchange

21 January 2018

1 reference

Comparative analysis of therapeutic options used for myasthenia gravis

21 January 2018

1 reference

Clinical applications of therapeutic apheresis

21 January 2018

1 reference

Comparison of IVIg and PLEX in patients with myasthenia gravis.

21 January 2018

1 reference

A retrospective study of complications of therapeutic plasma exchange in myasthenia

21 January 2018

1 reference

Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome

21 January 2018

1 reference

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

21 January 2018

1 reference

Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica.

21 January 2018

1 reference

Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder

21 January 2018

1 reference

Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months.

21 January 2018

1 reference

The rescue effect of plasma exchange for neuromyelitis optica

21 January 2018

1 reference

Treatment of steroid unresponsive relapse with plasma exchange in aggressive multiple sclerosis

21 January 2018

1 reference

Paraproteinemic neuropathy.

21 January 2018

1 reference

Neuropathy associated with monoclonal gammopathies of undetermined significance

21 January 2018

1 reference

Polyneuropathy associated with IgA monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

Chorea in fifty consecutive patients with rheumatic fever

21 January 2018

1 reference

Persistent Sydenham's chorea

21 January 2018

1 reference

Treatment of Sydenham's chorea with intravenous immunoglobulin, plasma exchange, or prednisone

21 January 2018

1 reference

Corticosteroids in the Treatment of Sydenham's Chorea

21 January 2018

1 reference

Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever

21 January 2018

1 reference

Advances in the management of PML: focus on natalizumab

21 January 2018

1 reference

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

21 January 2018

1 reference

Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab

21 January 2018

1 reference

Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function

21 January 2018

1 reference

Progressive multifocal leukoencephalopathy in patients with multiple sclerosis

21 January 2018

1 reference

Immune reconstitution inflammatory syndrome in natalizumab-associated PML.

21 January 2018

1 reference

21 January 2018

Guillain-Barré syndrome

1 reference

Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis

21 January 2018

1 reference

Treatment of Myasthenia Gravis Exacerbation With Intravenous Immunoglobulin

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCA.21331

1 reference

21 June 2017

1 reference

PubMed ID

24890467